Systematix Corp. (SYSTMTXC)

Cyclical

FairStock Score: 35/100 — MIXED

Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹59.71
Market Cap₹816.52 Cr
P/E Ratio28.43
ROCE25.09%
ROE30.8%
Dividend Yield0.13%
Profit Growth-96.93%
Debt/Equity0.06
Sales Growth53.3%
Promoter Holding70.58%
52-Week Range₹51.89 — ₹177.9
SectorCapital Markets
Book Value₹22.9

Strengths

Concerns

AI Analysis

At ₹74.44, the market prices Systematix at ₹1,030 crore. A stockbroker's earnings are a cyclical animal; in a dull quarter, sales of ₹34 crore produced just ₹1 crore of net profit. TTM profit has fallen almost 97%, so the headline P/E of 35.74 is not a sign of quality but of collapsing earnings. Book value is only ₹7.38, yet I am asked to pay 10 times that. That is a Graham warning: no margin of safety. ROE of 30.80% and ROCE of 25.09% look brilliant, but they are backward-looking and distorted by a tiny equity base; when earnings normalise, these numbers can reverse violently. The balance sheet is clean — D/E of 0.06 — and promoter holding at 70.58% aligns owners with us. Piotroski F-score of 3/9 tells me fundamentals are deteriorating, not improving. Sales growth is -20.51%, and the latest quarter's profit of ₹1 crore is barely a rounding error against the ₹1,030 crore market cap. I cannot call this an investment; it is a speculation on a rebound in broking volumes. In stockbroking, there is no durable moat unless the firm has a low-cost franchise or sticky client assets; nothing here proves that. The 52-week range of ₹51.89 to ₹177.90 shows a classic cyclical swing. I would wait for a higher F-score, stabilised profits, and a price closer to book value or a clear earnings recovery. As Benjamin Graham said, price is what you pay, value is what you get. Here the price demands future perfection, while the present financials demand caution.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer